Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Ariadne Diagnostics (United States)

InstitutionResearch output, impact & collaborations

Ariadne Diagnostics (United States) is a research organisation in Rockville, US. OpenAlex records 1,069 works and 192,636 citations for it. 196 researchers list it as their most recent affiliation.

1,069
Works
192,636
Citations
196
Researchers
57.5
Avg h-index

How has Ariadne Diagnostics (United States)'s publication output changed over time?

ScholarIQpublication output · 1999–2017

Output grew0% over the shown period — from 1 works in 1999 to 1 in 2017.

1
1
1
199920162017

What are the most-cited papers on Ariadne Diagnostics (United States)?

ScholarIQmost cited works
Analysis of human transcriptomes
Victor E. Velculescu, Stephen L Madden, Lin Zhang, Alex Lash, Jian Yu, Carlo Rago, Anita Lal, Clarence J. Wang, Gary A. Beaudry, Kristin M Ciriello, Brian P. Cook, Michael R. Dufault, Anne Ferguson, Yuhong Gao, Tong‐Chuan He, Heiko Hermeking, Siewleng K Hiraldo, Paul M. Hwang, Marissa A Lopez, Hilary F. Luderer, Brynna Mathews, Joseph M. Petroziello, Kornélia Polyák, Leigh Zawel, Wen Zhang, Xiaoming Zhang, Wei Zhou, Frank G. Haluska, Jin Jen, Saraswati Sukumar, Gregory M. Landes, Gregory J. Riggins, Bert Vogelstein, Kenneth W. Kinzler
S137905309. 1999791 Citations
Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase–Positive Non–Small-Cell Lung Cancer: A Randomized, Multicenter Phase II Trial
Dong‐Wan Kim, Marcello Tiseo, Myung‐Ju Ahn, Karen L. Reckamp, Karin Holmskov Hansen, Sang‐We Kim, Rudolf M. Huber, Howard West, Harry J.M. Groen, Maximilian J. Hochmair, Natasha B. Leighl, Scott Gettinger, Corey J. Langer, Luis G. Paz-Ares Rodríguez, Egbert F. Smit, Edward S. Kim, William M. Reichmann, Frank G. Haluska, David Kerstein, D. Ross Camidge
Journal of Clinical Oncology. 2017585 CitationsOPEN ACCESS
Activity and safety of brigatinib in ALK-rearranged non-small-cell lung cancer and other malignancies: a single-arm, open-label, phase 1/2 trial
Scott Gettinger, Lyudmila Bazhenova, Corey J. Langer, Ravi Salgia, Kathryn A. Gold, Rafael Rosell, Alice T. Shaw, Glen J. Weiss, Meera Tugnait, Narayana I. Narasimhan, David J. Dorer, David Kerstein, Victor M. Rivera, Timothy Piers Clackson, Frank G. Haluska, David Ross Camidge
The Lancet Oncology. 2016352 Citations

How much of the research on Ariadne Diagnostics (United States) is open access?

ScholarIQopen access share
33%OPEN ACCESS
Gold
0%
Green
33%
Hybrid
0%
Bronze
0%
Closed
67%

Related on ScholarIQ

Chronic Myeloid Leukemia Treatments
Top Topic
Chronic Lymphocytic Leukemia Research
Top Topic
Global Maternal and Child Health
Top Topic
Palliative Care and End-of-Life Issues
Top Topic
Lung Cancer Treatments and Mutations
Top Topic
Acute Lymphoblastic Leukemia research
Top Topic
470M+ articles · free account